Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Consumer Reports warns that there are important considerations, especially for older adults, before starting these treatments ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

The drugs were originally developed to treat type 2 diabetes, but have revolutionised the treatment of obesity after Wegovy was licensed ... higher than the year before. Senior author Klara ...

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

The first clinical trial of its kind found the weekly jab semaglutide, also known as Ozempic and Wegovy, cuts the amount ... The new study comes after UK figures published last week showed deaths ...

Like all reputable services, you must undergo lab tests before a healthcare professional ... A range of telehealth companies will prescribe Wegovy after a person has a health consultation with ...

The first clinical trial of its kind found the weekly jab semaglutide, also known as Ozempic and Wegovy, cuts the amount ... The new study comes after UK figures published last week showed deaths ...

Adults with obesity or who were overweight lost 15% of their body weight on average after taking Wegovy for one year ... say more long-term data is needed before committing patients to this ...